Calidi Biotherapeutics Inc (CLDI)
0.2387
+0.01
(+5.39%)
USD |
NYAM |
May 23, 16:00
0.2331
-0.01
(-2.35%)
After-Hours: 20:00
Calidi Biotherapeutics Cash from Investing (Quarterly): -0.005M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.005M |
| December 31, 2023 | -0.035M |
| September 30, 2023 | 0.074M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.137M |
| September 30, 2022 | -0.333M |
| September 30, 2021 | -0.188M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.333M
Minimum
Sep 2022
0.074M
Maximum
Sep 2023
-0.104M
Average
-0.086M
Median
Cash from Investing (Quarterly) Benchmarks
| Minerva Neurosciences Inc | 0.00 |
| Viking Therapeutics Inc | -459.79M |
| CytomX Therapeutics Inc | 44.88M |
| Genprex Inc | -0.0158M |
| Janux Therapeutics Inc | -113.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.831M |
| Cash from Financing (Quarterly) | 3.013M |
| Free Cash Flow | -22.68M |
| Free Cash Flow Per Share (Quarterly) | -0.1079 |
| Free Cash Flow Yield | -313.4% |